Conatus Pharmaceuticals Inc. To Present At Piper Jaffray And Oppenheimer Healthcare Conferences In December
SAN DIEGO, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that its management team will present at the following upcoming conferences in December:
Help employers find you! Check out all the jobs and post your resume.